Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of TNFAIP3, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis

H. Matsuoka,Daijiro Kabata,A. Taura,Toshihiro Matsui,Koichiro Takahi,Fuminori Hirano,M Katayama,Akira Okamoto,Y. Suenaga,Eiichi Suematsu,Shigeru Yoshizawa,Koichiro Ohmura,Satoshi Ito,Hirokazu Takaoka,Eri Oguro,Kentaro Kuzuya,Yasutaka Okita,Chikako Udagawa,M. Yoshimura,S. Teshigawara,Y Harada,Kentaro Isoda,Yuji Yoshida,Shiro Ohshima,Shigeto Tohma,Yukihiko Saeki

Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of TNFAIP3, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis

2020

Biological disease-modifying anti-rheumatic drugs (bDMARDs) against pathogenic proinflammatory cytokines and lymphocytes, such as tumour necrosis factor-α (TNF-α), interleukin-6, T cells and B cell...

Keywords:

Single-nucleotide polymorphism
Necrosis
therapeutic failure
Internal medicine
Disease
Rheumatoid arthritis
Diabetes mellitus
Gastroenterology
Medicine
Physical therapy
TNFAIP3

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations